TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Similar documents
Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Fighting Today s Opioid Epidemic

State Opioid Response (SOR) Grant

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

PHMC Integrated Health Services Overview

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

Closing the Loop in Treating Opioid Addiction:

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

Improving the Quality of Addiction Treatment

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations

New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door

STATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

Opportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths

ADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018

Management Options for Opioid Dependence:

Maryland Medicaid and Opioid Epidemic

ADAPTING YOUR COURT STRUCTURE

Aetna s Initiative on the Opioid Epidemic

BUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES

Potential Solutions to Epidemic Substance Abuse in US and Europe

Successful Prevention Strategies to Address the Opioid Crises

Project Connections Buprenorphine Program

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

Daniel Blaney-Koen, JD July 2018

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

RI Centers of Excellence for the

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Progress Report Maine Opiate Collaborative Recommendations. on the. October 2018

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

From Medicaid Transformation Approved Project Toolkit, June 2017

Status of Opioid Treatment Efforts

Division of Mental Health and Addiction Services

SUMMIT ON REDUCING THE SUPPLY OF ILLEGAL OPIOIDS IN WASHINGTON. Legislative Action: Opportunities and Challenges June 16, 2017

Building capacity for a CHC response to Ontario's Opioid Crisis

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Governor Raimondo s Task Force on Overdose Prevention and Intervention May 9, 2018

Changing Course: statewide efforts to combat the opioid epidemic in California

Mobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Medication Assisted Treatment

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Aligning Evidence-Based Practices with CCBHC Financing, Operations, and Quality Reporting. October 25th, :00pm 3:00pm

State Targeted Opioid Response Initiative (STORI) Fee-for-Service (FFS) Open Enrollment

OUD & MAR: Caring for Our Communities

Addressing the Opioid Epidemic in Tennessee

Improving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership

Hospitals Role in Addressing the Opioid Crisis

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Vivitrol Drug Court and Medication Assisted Treatment

Treatment Alternatives for Substance Use Disorders

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Opioid Overview Admiral Brett P. Giroir, M.D.

Child Welfare and MOMS: Building Partnerships to Improve Care

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

Prescription Opioid Overdose in Oregon: A public health perspective

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Combating Opiate Addiction

Medications for Addiction Treatment in the Mental Health and Physical Health Sectors

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

Best Practices for Successful Reentry for People with an Opioid Addiction

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Alamance County Leadership Forum Follow-up Report

The CARA & Buprenorphine Prescribing for APNs & PAs

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

Substance Abuse Suboxone Treatment

Ryan White Programs Provision of Substance Use Treatment

Medicaid s Role in Addressing Substance Use Disorders Through Innovative Care Pathways

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Serious Mental Illness and Opioid Use Disorder

Medicaid Expansion: Its Critical Role in Ohio s Response to the Addiction Crisis

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Patient and Family Agreement on Opioids

Opioid Use Issues: All the Players

Maryland Association of Healthcare Executives presents:

OPIOID WORKGROUP LEADERSHIP TEAM

Methadone Maintenance 101

Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018

Substance Use Disorders: A Path Forward for Michigan

Medication Assisted Treatment. Nicole Gastala, MD

Transcription:

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016

SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health Officer, Health Care for the Homeless (Baltimore, MD) Terry Clark, Addictions Counselor, Health Care for the Homeless (Baltimore, MD) Brianna Sustersic, MD, Senior Medical Director of Primary Care, Central City Concern (Portland, OR) Brian Barnes, Clinical Supervisor, Central City Concern (Portland, OR) Barbara DiPietro (Moderator), Senior Director of Policy, National HCH Council

WHY THIS ISSUE? Growing problem of addiction in U.S. now recognized as epidemic Long-term issue among vulnerable populations; causes and prolongs homelessness Homeless adults age 25-44 9x more likely to die from opioid overdose than housed peers (Boston study) HCH providers well-versed in integrated, harm reduction model of care to address opioid addiction Number of Deaths 20,000 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 U.S. Overdose Deaths, 1999-2014 Prescription Opioids Heroin Year Source: Centers for Disease Control and Prevention, 2014

WHY THIS ISSUE? Source: Centers for Disease Control and Prevention, 2014

UNDERSTANDING MAT Use of medications in combination with counseling and behavioral therapies Three MATs: methadone, naltrexone, buprenorphine Buprenorphine first medication permitted to be prescribed and/or dispensed in physicians office Suppresses withdrawal, decreases cravings, lowers risk of overdose Increases access to treatment in primary care setting Highly regulated: physician-only prescribing rights, required trainings & recordkeeping, patient limits, waiver authorizations, health insurance regulations

FEDERAL LEVEL CHANGES Congress: Comprehensive Addiction and Recovery Act Grants to expand access to overdose reversal drugs (Naloxone/Narcan) Grants to expand treatment alternatives to incarceration Expands buprenorphine prescribing rights to NPs and PAs Furthers movement towards treating addiction as a disease, not a criminal activity Administration: Dept of Health & Human Services (HHS) Raising the MAT patient cap to 275 HRSA grants to health centers SAMHSA grants to increase SUD training and expand MAT Reduce over prescribing with updated training and prescriber guidelines

CHALLENGES PROVIDING MAT Lack of training in identifying and treating SUD among primary care providers Limited capacity in health centers to meet demand Diversion and misuse of medication High costs, differing insurance plans & Medicaid state policies Non-Medicaid expansion states: greater difficulty accessing SUD care Difficulties specific to homelessness Lack of stability, social supports, transportation, income Negative experiences in health care systems Difficulty adhering to daily care plan High rate of comorbidities Focus on basic daily needs

OVERCOMING CHALLENGES: PROVIDER PRACTICES Establish stability in housing Address comorbidities using integrated care Treat the whole person Take a low-barrier, harm reduction approach Use evidence-based best practices Be patient centered Be flexible

OVERCOMING CHALLENGES: POLICY RECOMMENDATIONS Remove patient caps & treat as any other medication Expand prescribing rights to all clinicians eligible to prescribe Class III, IV and V CDS drugs Require training to prescribe all opioids Enforce parity laws (especially re: prior authorizations) Reduce stigma and treat addiction as a disease Train all health care providers on addiction Expand prevention and treatment programs Reduce incarceration in response to addiction behaviors

Health Care for the Homeless: Baltimore, MD FQHC serving over 10,000 people experiencing homelessness a year 3 primary care clinics Downtown Baltimore West Baltimore Baltimore County Services offered: medical, behavioral health, dental, nursing, case management, outreach, supportive housing Treatment philosophy Person centered Trauma informed Harm reduction Multidisciplinary care teams Patients served Current MAT initiation: 60 MAT in the past year: 500

Entering Care No wrong door: addictions counselors and medical providers conduct warm hand offs Comprehensive multidisciplinary care with Mental health Case management Nursing Dental Supportive Housing On-site pharmacy Naloxone training

Initiating MAT Treatment agreement PDMP review Most clients have taken buprenorphine in the past Client managed induction once in withdrawal Daily group meetings Weekly individual counselor sessions Weekly MAT group for buprenorphine adjustment Weekly urine screens

Maintenance Transition to primary care provider or psychiatrist 4 physicians 5 NPs who co-manage with MDs 4 psychiatrists Continue individual therapy/counseling Dual diagnosis group

Central City Concern: Portland, OR Old Town Clinic is a Healthcare for the Homeless FQHC primary care medical home, housed within the larger social services agency of CCC. We strive to provide low barrier, patient centered, and holistic care. Our MAT philosophy: MAT is most effective when offered as part of a comprehensive and individualized treatment program, which includes medication, counseling and community support. SUD treatment is fully integrated into primary care: Warm hand-offs to addictions counselors Range of SUD treatment groups on-site: dual diagnosis, pain management, understanding addiction Weekly case consultation with provider champions Number of patients being treated with buprenorphine: 167 in the last year; 45 currently active patients

Central City Concern: Portland, OR Started MAT program in 2013 with 1 counselor and a couple of prescribers > we now have 3 counselors, 1 clinical supervisor, 1 admin assistant, and 8 prescribers Our response to the challenges: Addressing stigma - changing language and culture around addiction Monitoring practices: pill counts, urine drug screens, bubble-packing of meds, treatment agreement, twice weekly group attendance required 5 beds available in supportive housing Onsite pharmacy - ongoing collaboration, multiple dispensing options including: bubble packing, daily dispense, weekly dispense Provider education addiction-trained physicians and nurse practitioners, frequent education sessions on substance use disorder topics Other wraparound services: specialty mental health, case management, benefits/employment assistance, housing Naloxone training, prescribing

QUESTION: APPROACH TO CARE MAT implies that medication is coupled with counseling and therapy. Do you find that counseling is necessary for all patients, or do some patients do well on medication alone? What does being patient-centered and flexible mean when crafting treatment plans for people who are homeless? Under what conditions would you stop treatment?

QUESTION: DIVERSION Diversion of buprenorphine is a topic of concern. From a public health perspective, how concerned are you about diversion and what steps do you take to mitigate it? Self treatment Possible risk v. other opiates Prescriber caps and other limits

QUESTION: BENEFITS TO MAT What are some of the benefits patients engaged in MAT have experienced? Increased stability Ability to address other health issues Ability to reconnect with family & social supports Ability to maintain housing, engage in work

OTHER QUESTIONS? Nilesh Kalyanaraman, MD, Chief Health Officer, Health Care for the Homeless (Baltimore, MD) Terry Clark, Addictions Counselor, Health Care for the Homeless (Baltimore, MD) Brianna Sustersic, MD, Senior Medical Director of Primary Care, Central City Concern (Portland, OR) Brian Barnes, Clinical Supervisor, Central City Concern (Portland, OR)